Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Efficacy, Safety and Tolerability of PF-06649751 in Parkinson’s Disease Patients With Motor Fluctuations: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089): Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Efficacy, Tolerability, and Safety of DFN-15: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, and Safety of DFN-15: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03009019).
- Efficacy, Tolerability, and Safety Study of DFN-15: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, and Safety Study of DFN-15: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03006276).
- Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01554956).
- Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01825512).
- Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Efficiency of the King Vision Video Laryngoscope: Complete Statistical AnalysisIndependent statistical analysis of Efficiency of the King Vision Video Laryngoscope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02482870).
- EFFORTIndependent statistical analysis of Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EffortIndependent statistical analysis of Effects of Smoking State on Decision Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04826276).
- EFFORTIndependent statistical analysis of Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01128413).
- EFforT-BCRLIndependent statistical analysis of Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02609724).
- Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin: Complete Statistical AnalysisIndependent statistical analysis of Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00601640).
- EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- EGFRIndependent statistical analysis of TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy: primary endpoint results, effect…
- EGGSOTIIndependent statistical analysis of Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia: Complete Statistical AnalysisIndependent statistical analysis of EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02722577).
- eHealth Evidence-based Intervention (EBI) for Latino Youth in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of eHealth Evidence-based Intervention (EBI) for Latino Youth in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03009539).
- eHELP ChinaIndependent statistical analysis of Rosuvastatin Adherence App Study in China: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02433288).
- EHPOCIndependent statistical analysis of Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04793750).
- EHR-WWCIndependent statistical analysis of EHR Embedded Comparative Effectiveness Studies--WWC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04514679).
- eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients: Complete Statistical AnalysisIndependent statistical analysis of eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EINSTEIN JrIndependent statistical analysis of EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02234843).
- Einstein JrIndependent statistical analysis of Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02564718).
- EinsteinChoiceComplete statistical analysis of the EinsteinChoice phase 3 trial of reduced-dose rivaroxaban for long-term prevention of recurrent symptomatic venous thromboembolism, including trial design, endpoints, hazard ratios, confidence intervals, safety, and statistical interpretation.
- EINSTEINJrIndependent statistical analysis of EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EiPAHIndependent statistical analysis of An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH): primary endpoint results, effect estimate with confidence interval, sample-size…
- EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00636155).
- Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH): Complete Statistical AnalysisIndependent statistical analysis of Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH): primary endpoint results, effect estimate with confidence interval, sample-size…
- ELARAIndependent statistical analysis of Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ELARIS EM-IIIndependent statistical analysis of A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain: primary endpoint results, effect estimate with confidence…
- ElbowHOIndependent statistical analysis of Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00991887).
- ELCIEIndependent statistical analysis of Effects of rhLactoferrin on Chronic Inflammation in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02968992).